Chart Review: Drug Utilization Study in Participants Who Received Ozurdex™ (Dexamethasone Intravitreal Implant) 0.7 mg Injections for Visual Impairment Due to Diabetic Macular Edema (DME)
Clinical trial NCT03889444 · COMPLETED
Trial details
- NCT number
- NCT03889444
- Sponsor
- Allergan
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-01-15
- Primary completion
- 2019-06-07
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.